Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study
- 浏览0
European journal of cancer
473-481页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



